Table of Content

1. PREFACE
1.1. Introduction
1.2. Key Market Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION
3.1. Chapter Overview
3.2. Introduction to Nanoparticles
3.3. Classification of Nanoparticles
3.3.1. Organic Nanoparticles
3.3.2. Inorganic Nanoparticles
3.3.3. Carbon-based Nanoparticles
3.4. Methods of Nanoparticle Formulation
3.5. Applications of Nanoparticle-based Systems
3.6. Challenges associated with Nanoparticle Formulation
3.7. Need for Outsourcing Nanoparticle Formulation
3.8 Concluding Remarks

4. TECHNOLOGY LANDSCAPE
4.1. Chapter Overview
4.2. Nanoparticle Formulation: Technology Landscape
4.2.1. Analysis by Type of Nanoparticle(s) Formulated
4.2.2. Analysis by Type of Organic Nanoparticle(s) Formulated
4.2.3. Analysis by Type of Inorganic Nanoparticle(s) Formulated
4.2.4. Analysis by Type of Molecule(s) Delivered
4.2.5. Analysis by Therapeutic Area(s)
4.2.6. Analysis by Compatible Dosage Form(s)
4.2.7. Analysis by Route(s) of Administration
4.3. Nanoparticle Formulation: Technology Developer Landscape
4.3.1. Analysis by Year of Establishment
4.3.2. Analysis by Company Size
4.3.3. Analysis by Location of Headquarters
4.3.4. Analysis by Company Size and Location of Headquarters
4.3.5. Most Active Players: Analysis by Number of Technologies

5. SERVICE PROVIDERS LANDSCAPE
5.1. Chapter Overview
5.2. Nanoparticle Formulation: Service Providers Landscape
5.2.1. Analysis by Year of Establishment
5.2.2. Analysis by Company Size
5.2.3. Analysis by Location of Headquarters
5.2.4. Analysis by Company Size and Location of Headquarters
5.2.5. Analysis by Location of Facilities
5.2.6. Analysis by Type of Service Provider(s)
5.2.7. Analysis by Type of Nanoparticle(s) Formulated
5.2.7.1. Analysis by Type of Organic Nanoparticle(s) Formulated
5.2.7.2. Analysis by Type of Inorganic Nanoparticle(s) Formulated
5.2.8. Analysis by Type of Service Provider(s) and Type of Nanoparticle(s) Formulated
5.2.9. Analysis by Service(s) Offered
5.2.10. Analysis by Company Size and Service(s) Offered
5.2.11. Analysis by Scale of Operation
5.2.12. Analysis by Application Area(s)

6. TECHNOLOGY COMPETITIVENESS ANALYSIS
6.1. Chapter Overview
6.2. Assumptions / Key Parameters
6.3. Methodology
6.4. Technology Competitiveness Analysis
6.4.1. Nanoparticle Formulation Technologies Offered by Players based in North America
6.4.1.1. Nanoparticle Formulation Technologies Offered by Small Players based in North America
6.4.1.2. Nanoparticle Formulation Technologies Offered by Mid-sized and Large Players based in North America
6.4.2. Nanoparticle Formulation Technologies Offered by Players based in Europe
6.4.3. Nanoparticle Formulation Technologies Offered by Players based in Asia-Pacific, Middle East and North Africa, and Rest of the World

7. COMPANY COMPETITIVENESS ANALYSIS
7.1. Chapter Overview
7.2. Assumptions / Key Parameters
7.3. Methodology
7.4. Company Competitiveness Analysis
7.4.1. Nanoparticle Formulation Service Providers based in North America
7.4.2. Nanoparticle Formulation Service Providers based in Europe
7.4.3. Nanoparticle Formulation Service Providers based in Asia-Pacific, and Middle East and North Africa

8. COMPANY PROFILES
8.1. Chapter Overview
8.2. Ascension Sciences
8.2.1. Company Overview
8.2.2. Technology Portfolio
8.2.3. Service Portfolio
8.2.4. Recent Developments and Future Outlook
8.3. DIANT Pharma
8.3.1. Company Overview
8.3.2. Technology Portfolio
8.3.3. Service Portfolio
8.3.4. Recent Developments and Future Outlook
8.4. ExonanoRNA
8.4.1. Company Overview
8.4.2. Technology Portfolio
8.4.3. Service Portfolio
8.4.4. Recent Developments and Future Outlook
8.5. Nanoform
8.5.1. Company Overview
8.5.2. Technology Portfolio
8.5.3. Service Portfolio
8.5.4. Recent Developments and Future Outlook
8.6. NanoVation Therapeutics
8.6.1. Company Overview
8.6.2. Technology Portfolio
8.6.3. Service Portfolio
8.6.4. Recent Developments and Future Outlook
8.7. NanoVelos
8.7.1. Company Overview
8.7.2. Technology Portfolio
8.7.3. Service Portfolio
8.7.4. Recent Developments and Future Outlook
8.8. NTT Biopharma
8.8.1. Company Overview
8.8.2. Technology Portfolio
8.8.3. Service Portfolio
8.8.4. Recent Developments and Future Outlook
8.9. Organoid-X BioTech
8.9.1. Company Overview
8.9.2. Technology Portfolio
8.9.3. Service Portfolio
8.9.4. Recent Developments and Future Outlook
8.10. Vaxinano
8.10.1. Company Overview
8.10.2. Technology Portfolio
8.10.3. Service Portfolio
8.10.4. Recent Developments and Future Outlook

9. PARTNERSHIPS AND COLLABORATIONS
9.1. Chapter Overview
9.2. Partnership Models
9.3. Nanoparticle Formulation Technologies and Services: Partnerships and Collaborations
9.3.1. Analysis by Year of Partnership
9.3.2. Analysis by Type of Partnership
9.3.3. Analysis by Year and Type of Partnership
9.3.4. Analysis by Type of Partner
9.3.5. Analysis by Location of Headquarters of Partner
9.3.6. Analysis by Type of Partnership and Location of Headquarters of Partner
9.3.7. Most Active Players: Analysis by Number of Partnerships
9.3.8. Analysis by Geography
9.3.8.1. Intercontinental and Intracontinental Deals
9.3.8.2. Local and International Deals

10. PATENT ANALYSIS
10.1. Chapter Overview
10.2. Scope and Methodology
10.3. Nanoparticle Formulation Domain: Patent Analysis
10.3.1. Analysis by Publication Year
10.3.2. Analysis by Type of Patent and Publication Year
10.3.3. Analysis by Geography
10.3.4. Analysis by CPC Symbols
10.3.5. Analysis by Type of Organization
10.3.6. Leading Industry Players: Analysis by Number of Patents
10.4. Patent Benchmark Analysis
10.4.1. Analysis by Patent Characteristics
10.5. Patent Valuation Analysis

11. NANOPARTCLE EVALUATION FRAMEWORK
11.1. Chapter Overview
11.2. Key Assumptions and Methodology
11.3. Organic Nanoparticles
11.3.1. Number of Clinical Trials
11.3.2. Extent of Innovation
11.3.3. Trends in Research Activity
11.3.4. Current Global Competition
11.3.5. Nanoparticle Evaluation Framework: Organic Nanoparticles
11.4. Inorganic Nanoparticles
11.4.1. Number of Clinical Trials
11.4.2. Extent of Innovation
11.4.3. Trends in Research Activity
11.4.4. Current Global Competition
11.4.5. Nanoparticle Evaluation Framework: Inorganic Nanoparticles
11.5. Carbon-based Nanoparticles
11.5.1. Number of Clinical Trials
11.5.2 Extent of Innovation
11.5.3. Trends in Research Activity
11.5.4. Current Global Competition
11.5.5. Nanoparticle Evaluation Framework: Carbon-based Nanoparticles
11.5.6. Nanoparticle Evaluation Framework: Concluding Remarks
12. MARKET FORECAST AND OPPORTUNITY ANALYSIS
12.1. Chapter Overview
12.2. Key Assumptions and Forecast Methodology
12.3. Global Nanoparticle Formulation Services Market, 2023-2035
12.4. Nanoparticle Formulation Services Market: Analysis by Type of Nanoparticle Formulated
12.4.1. Nanoparticle Formulation Services Market: Analysis by Type of Organic Nanoparticle Formulated
12.4.1.1. Nanoparticle Formulation Services Market for Polymeric Nanoparticles, 2023-2035
12.4.1.2. Nanoparticle Formulation Services Market for Lipid Nanoparticles, 2023-2035
12.4.1.3. Nanoparticle Formulation Services Market for Viral Nanoparticles, 2023-2035
12.4.1.4. Nanoparticle Formulation Services Market for Protein-based Nanoparticles, 2023-2035
12.4.1.5. Nanoparticle Formulation Services Market for Other Organic Nanoparticles, 2023-2035
12.4.2. Nanoparticle Formulation Services Market: Analysis by Inorganic Nanoparticle Formulated
12.4.3. Nanoparticle Formulation Services Market: Analysis by Carbon-based Nanoparticle Formulated
12.5. Nanoparticle Formulation Services Market: Analysis by Scale of Operation
12.5.1. Nanoparticle Formulation Services Market for Preclinical Operations, 2023-2035
12.5.2. Nanoparticle Formulation Services Market for Clinical Operations, 2023-2035
12.5.3. Nanoparticle Formulation Services Market for Commercial Operations, 2023-2035
12.6. Nanoparticle Formulation Services Market: Analysis by Key Geographical Regions
12.6.1. Nanoparticle Formulation Services Market in North America, 2023-2035
12.6.2. Nanoparticle Formulation Services Market in Europe, 2023-2035
12.6.3. Nanoparticle Formulation Services Market in Asia-Pacific, 2023-2035
12.6.4. Nanoparticle Formulation Services Market in Middle East and North Africa, 2023-2035
12.6.5. Nanoparticle Formulation Services Market in Latin America, 2023-2035

13. CASE STUDY: TECHNOLOGY LICENSING DEALS
13.1. Chapter Overview
13.2. Recent Technology Licensing Deals
13.3. Concluding Remarks

14. CONCLUSION

15. EXECUTIVE INSIGHTS

16. APPENDIX 1: TABULATED DATA

17. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS